‘Famous cancer insurance family’ Hanwha Life Insurance(CEO and Vice Chairman Seung-joo Yeo) announced on the 4th (Monday) that it has launched “Hanwha Life Insurance The Signature Cancer Insurance,” which significantly expands the treatment coverage amount by reflecting the advancement of cancer treatment technology and the latest insurance consumption trends.
The maximum payment amount for existing major cancer treatment products has been expanded, and the maximum payment period for high-cost treatment products such as targeted anti-cancer drug therapy and specific immune anti-cancer drug therapy has been expanded. In addition, we have developed an ‘integrated cancer special contract’ that guarantees diagnostic funds for even metastatic cancer.
Main features First, the maximum guaranteed amount for ‘major cancer treatment expenses’ was increased from 100 million won to 150 million won. The existing minimum coverage standard of 5 million won was maintained the same. By allowing customers to receive coverage for high treatment costs while maintaining the minimum coverage amount, we have increased the likelihood that customers will receive the coverage they need. ‘Major cancer treatment’ refers to cases where a customer receives cancer surgery, anti-cancer drug treatment, or anti-cancer radiation treatment after being diagnosed with cancer.
Second, under the ‘integrated cancer special contract’, cancer is divided into 10 groups regardless of primary cancer or metastatic cancer, and cancer diagnosis funds are paid once per group, up to 10 times. Customers can receive cancer diagnosis funds multiple times with one product, allowing them to raise sufficient funds for cancer diagnosis at a low cost.
Third, benefits for high-cost treatment were strengthened. The coverage period for targeted anti-cancer drugs and non-reimbursed target anti-cancer drugs, which were previously covered for 5 years, has been extended to 10 years. Among the major cancer treatments, the cost of targeted anti-cancer drug treatment, non-covered targeted anti-cancer drug treatment, and specific immune anti-cancer drug treatment, which are expensive, is provided in a flat amount every year for 10 years. For cancer robot surgery, insurance premiums are paid according to the number of surgeries until maturity.
The scope of payment exemption has also been expanded. Colon mucosal cancer and early breast cancer have been added to the cancer payment exemption list, so you can receive an insurance premium exemption when diagnosed with cancer. In addition, it is equipped with major popular benefits such as cancer surgery, cancer hospitalization/outpatient care, and disease aftereffects.
Changhee Koo, head of the product development team at Hanwha Life Insurance, said, “Hanwha Life Insurance The Signature Cancer Insurance” is equipped with integrated cancer coverage that covers not only major cancer treatment costs but also metastatic cancer diagnosis, and special contracts for cancer hospitalization and outpatient treatment, providing customers with total coverage for cancer. “We have prepared this to allow for this,” he said, adding, “We will continue to develop new coverage in line with the advancement of cancer treatment technology.”
The age limit for this product is from 15 to 80 years old.
Age 40, maturity at age 100, payment in 20 years (for renewal type, payment in full at maturity in 20 years), main contract 1 million won, major cancer treatment coverage S special contract[암(기타피부암·갑상선암 제외)](Once a year) 10 million won, cancer treatment expenses (main cancer treatment expenses) support S special contract[5백만원이상] 150 million won, targeted anticancer drug approved treatment S special contract (once a year) 10 million won, non-reimbursed targeted anticancer drug approved treatment S special contract (once a year) 10 million won, specific immune anticancer drug approved treatment S special contract (once a year) ( Renewal type) 10 million won, special contract for cancer robot surgery S[다빈치&레보아이](per time) (renewable type) When signing up for 10 million won, the monthly insurance premium is 30,592 won for men and 30,406 won for women for the general subscription type product, and 37,944 won for men and 38,187 won for women for the simple subscription type product.
Meanwhile, subscribers are provided with a ‘cancer protection system’ as an additional service that manages everything before and after a cancer diagnosis. The cancer protection system is a service provided by ‘Need,’ a global company in partnership with Hanwha Life Insurance. We support customers with early cancer detection and confirmation of recurrence/metastasis, and support doctors in establishing treatment plans through an AI information platform.
